Comparative evaluation of the antibody in lymphocyte supernatant (ALS) and enzyme-linked immunospot (ELISPOT) assays for measuring mucosal immune responses to Shigella antigens
- 1 November 2011
- Vol. 29 (47) , 8487-8489
Abstract
No abstract availableKeywords
Funding Information
- USAMRMC (DAMD17-01-D-0011)
- National Center for Research Resources, NIH (M01-RR00052)
- Salix Pharmaceuticals
- DHHS
- NIH
- National Eye Institute Training (EY07127, Clinical Trials Training Program in Vision Research)
This publication has 15 references indexed in Scilit:
- Changing Epidemiology of Shigellosis and Emergence of Ciprofloxacin-Resistant Shigellae in IndiaJournal of Clinical Microbiology, 2007
- A Multicentre Study of Shigella Diarrhoea in Six Asian Countries: Disease Burden, Clinical Manifestations, and MicrobiologyPLOS Medicine, 2006
- Rifaximin, a Nonabsorbed Oral Antibiotic, Prevents Shigellosis after Experimental ChallengeClinical Infectious Diseases, 2006
- Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteersVaccine, 2006
- Comparative Safety and Immunogenicity of Two Attenuated Enterotoxigenic Escherichia coli Vaccine Strains in Healthy AdultsInfection and Immunity, 2006
- Comparison of the Antibodies in Lymphocyte Supernatant and Antibody-Secreting Cell Assays for Measuring Intestinal Mucosal Immune Response to a Novel Oral Typhoid Vaccine (M01ZH09)Clinical and Vaccine Immunology, 2005
- Antigen-Specific Immunoglobulin A Antibodies Secreted from Circulating B Cells Are an Effective Marker for Recent Local Immune Responses in Patients with Cholera: Comparison to Antibody-Secreting Cell Responses and Other Immunological MarkersInfection and Immunity, 2003
- Construction and Characterization of Genetically Defined aro omp Mutants of Enterotoxigenic Escherichia coli and Preliminary Studies of Safety and Immunogenicity in HumansInfection and Immunity, 2001
- Development of a Novel In Vitro Assay (ALS Assay) for Evaluation of Vaccine-Induced Antibody Secretion from Circulating Mucosal LymphocytesClinical and Diagnostic Laboratory Immunology, 2001
- Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteersVaccine, 1999